local_hospital

Spitalul Clinic Judetean Mures

Address
lock Available on a paid plan

Gastroenterology and Inflammatory Bowel Disease

At Spitalul Clinic Judetean Mures, clinical research in digestive system diseases focuses on Crohn’s disease, ulcerative colitis, and bile acid diarrhoea. These studies are designed to test new treatment options and assess how well they control symptoms and improve intestinal healing.

  • Evaluating therapies for Crohn’s disease and ulcerative colitis
  • Studying treatment effectiveness in bile acid diarrhoea
  • Improving relief of inflammation and digestive symptoms

The site’s work in this area highlights a strong interest in finding better ways to manage chronic gastrointestinal inflammation and related quality-of-life concerns.

Cardiovascular Medicine and Stroke Prevention

Research in cardiovascular diseases includes acute coronary syndrome, myocardial infarction, atrial fibrillation, heart failure, and atherosclerotic cardiovascular disease. The trials are mainly aimed at preventing major events, reducing complications, and improving long-term cardiovascular outcomes.

  • Testing approaches to prevent stroke and recurrent heart events
  • Evaluating treatments for atrial fibrillation and heart failure
  • Supporting better prevention in high-risk cardiovascular disease

This area reflects a broad effort to improve both acute care and prevention strategies for patients with serious heart and vascular conditions.

Dermatology, Immune-Mediated Disease, and Allergy

Trials in skin and connective tissue diseases and immune system diseases cover plaque psoriasis, prurigo nodularis, and cutaneous lupus erythematosus. The main purpose is to evaluate new therapies that may better control inflammation, itching, and visible skin symptoms.

  • Assessing treatments for moderate to severe plaque psoriasis
  • Studying options for prurigo nodularis and persistent itch
  • Exploring therapies for cutaneous lupus erythematosus

These studies show active interest in improving care for chronic inflammatory skin disorders that can significantly affect daily life.

Oncology and Hematology

The site’s neoplasms research includes breast cancer, prostate cancer, and chronic lymphocytic leukemia. In parallel, work in hemic and lymphatic diseases aims to evaluate new treatments that may improve disease control and patient outcomes.

  • Testing therapies for HER2-positive breast cancer
  • Studying treatment strategies in high-risk prostate cancer
  • Evaluating approaches for chronic lymphocytic leukemia

Research in this field supports the development of more effective cancer and blood-disease treatments at Spitalul Clinic Judetean Mures.

Respiratory and Critical Care Research

Clinical trials in respiratory tract diseases focus on acute respiratory distress syndrome linked to pneumonia or other infections. The aim is to assess new therapies that may help improve breathing, recovery, and survival in severely ill patients.

  • Evaluating treatments for ARDS caused by infection
  • Exploring ways to improve outcomes in critical respiratory illness
  • Supporting better management of severe lung inflammation

This work addresses a high-risk area of care where improved treatment options could make a meaningful difference for hospitalized patients.

Endocrinology and Growth Disorders

Research in hormonal diseases includes Cushing’s disease, growth hormone deficiency, and childhood growth problems such as idiopathic short stature, short stature due to SHOX deficiency, Turner syndrome, and small for gestational age. These trials are designed to assess new treatments and their impact on hormone balance and growth.

  • Testing therapies for Cushing’s disease
  • Evaluating treatment options for growth failure in children and adolescents
  • Studying ways to support healthier growth outcomes

The site’s endocrinology research spans both rare disorders and pediatric growth conditions, with a strong focus on improving long-term care.

Psychiatry and Behavioral Health

Trials in mental disorders and behavioral disciplines focus on schizophrenia. The research is intended to evaluate whether new or added treatments can better reduce symptoms and improve day-to-day functioning for patients with ongoing psychiatric needs.

  • Assessing symptom control in schizophrenia
  • Studying adjunctive treatment approaches for persistent symptoms
  • Supporting improved psychiatric care for hospitalized adults

This area adds an important mental health dimension to the site’s broader clinical research portfolio.

Infectious Disease, Surgery, and Prevention Research

Studies in bacterial infections and mycoses include prevention of post-abdominal surgery incisional infection. The purpose is to test methods that may lower infection risk and improve recovery after surgery.

  • Preventing surgical site infection after abdominal procedures
  • Evaluating infection-control strategies in surgical care
  • Improving postoperative safety and healing

This research supports practical improvements in hospital-based infection prevention and surgical outcomes.

Reproductive Health and Contraception

Within reproductive and urinary physiological phenomena, the site is involved in a study of contraceptive efficacy. The goal is to determine how well the method prevents pregnancy while also assessing overall tolerability and safety.

  • Evaluating a new contraceptive option
  • Studying pregnancy prevention effectiveness
  • Assessing user acceptability and safety

This adds a women’s health perspective to the broader research activity at the site.

Rheumatology and Autoimmune Disease

Research in immune system diseases and skin and connective tissue diseases also includes autoimmune conditions such as lupus. These trials aim to test therapies that may better control inflammation and reduce disease-related skin manifestations.

  • Studying treatment effects in cutaneous lupus erythematosus
  • Exploring improved control of autoimmune inflammation
  • Evaluating symptom relief in chronic immune-mediated disease

Such studies help expand options for patients with complex autoimmune disorders that often require long-term management.

Site Overview

assignment
33
connected trials
corporate_fare
24
sponsors
science
41
IMPs

Activity Indicator

Last 6 months

2
Trials started
-33% vs previous period.
3
Trials started 6–12 months ago
33
Total trials linked
Highly Active
trending_downDeclining-33%
1
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 15 therapeutic areas and 15 of 41 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
12
Sponsors (total)
24
Active sponsors
12

Sponsor Network

Top 12 by active trials.

lock +11 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +5 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 442 other sites in Romania

description
Trial volume
33
Outperforms 93% of sites
public
Therapeutic diversity
15areas
Outperforms 99% of sites
groups
Sponsor diversity
24sponsors
Outperforms 95% of sites

Therapeutic Area Benchmark — Romania

Select a therapeutic area to compare against other sites in Romania.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Romania

Market Share

Country: Romania

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Spitalul Clinic Judetean Mures

lock Showing 1 of 33 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Deucravacitinib (BMS-986165) in Pediatric Subjects with Moderate to Severe Plaque PsoriasisBristol-Myers Squibb Services Unlimited CompanyPhase IIIRecruitingMay 2021

IMP list

lock Showing 1 of 41 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Milvexian3Unknown2023-08-042023-11-21

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.